ASCO Daily News

134 Folgen

1. Novel Therapies in GI Oncology at ASCO22

   Vom: 27.6.2022
2. Spotlight on Immunotherapy at ASCO22

   Vom: 23.6.2022
3. Advances in Hematologic Malignancies at ASCO22

   Vom: 22.6.2022
4. DESTINY-Breast04 and Other Key Breast Cancer Studies at ASCO22

   Vom: 21.6.2022
5. Advances in Genitourinary Cancers at ASCO22

   Vom: 18.6.2022
6. Advances in Lung Cancer at ASCO22

   Vom: 17.6.2022
7. ASCO22 Scientific Program: Dynamic Sessions and Advances Across the Spectrum of Malignancies

   Vom: 1.6.2022
8. ASCO22: Key Posters on Advances in Immunotherapy

   Vom: 27.5.2022
9. ASCO22: Key Advances in Hematologic Malignancies

   Vom: 27.5.2022
10. ASCO22: Novel Therapies in Breast Cancer

    Vom: 27.5.2022
11. ASCO22: Key Posters on Advances in GI Oncology

    Vom: 26.5.2022
12. ASCO22: Novel Therapies in Lung Cancer

    Vom: 26.5.2022
13. Key Posters on Advances in GU Cancers at ASCO22

    Vom: 26.5.2022
14. ASCO22: Addressing Challenges in Cancer Care With Dr. Neeraj Agarwal

    Vom: 26.5.2022
15. ASCO22 Education Program Preview: Advancing Equity, Innovation, and Impact

    Vom: 24.5.2022
16. Guidance on Cannabis Use in Palliative Oncology

    Vom: 19.5.2022
17. How AA & NHPI Aggregation Masks Cancer Disparities

    Vom: 5.5.2022
18. The Time Toxicity of Cancer Treatment

    Vom: 21.4.2022
19. Highlights From the 2022 NCCN Annual Conference

    Vom: 14.4.2022
20. Addressing the Needs of Millions of Cancer Survivors

    Vom: 7.4.2022